Profil

Viatour Patrick

See author's contact details
Main Referenced Co-authors
Chariot, Alain  (10)
Merville, Marie-Paule  (10)
Bours, Vincent  (8)
Keutgens, Aurore  (4)
Chapelle, Jean-Paul  (3)
Main Referenced Keywords
NF-kappa B (6); BCL-3 (5); I kappa B (2); NF kappa B (2); phosphorylation (2);
Main Referenced Unit & Research Centers
Giga-Signal Transduction - ULiège [BE] (5)
GIGA‐R - Giga‐Research - ULiège [BE] (2)
Giga-Signal Transduction, GIGA-R (1)
Main Referenced Disciplines
Biochemistry, biophysics & molecular biology (9)
Hematology (2)
Oncology (2)
Laboratory medicine & medical technology (1)
Pharmacy, pharmacology & toxicology (1)

Publications (total 12)

The most downloaded
5671 downloads
Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (January 2005). Phosphorylation of NF-kappa B and I kappa B proteins: implications in cancer and inflammation [letter to the editor]. Trends in Biochemical Sciences, 30 (1), 43-52. doi:10.1016/j.tibs.2004.11.009 https://hdl.handle.net/2268/1280

The most cited

1261 citations (Scopus®)

Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (January 2005). Phosphorylation of NF-kappa B and I kappa B proteins: implications in cancer and inflammation [letter to the editor]. Trends in Biochemical Sciences, 30 (1), 43-52. doi:10.1016/j.tibs.2004.11.009 https://hdl.handle.net/2268/1280

Keutgens, A., Shostak, K., Close, P., Zhang-Shao, X., Hennuy, B., Aussems, M., Chapelle, J.-P., Viatour, P., Gothot, A., Fillet, M., & Chariot, A. (August 2010). The repressing function of the oncoprotein BCL-3 requires CtBP while its polyubiquitination and degradation involve the E3 ligase TBLR1. Molecular and Cellular Biology, 30, 4006-4021. doi:10.1128/MCB.01600-09
Peer Reviewed verified by ORBi

Keutgens, A., Zhang-Shao, X., Shostak, K., Robert, I., Olivier, S., Vanderplasschen, A., Chapelle, J.-P., Viatour, P., Merville, M.-P., Bex, F., Gothot, A., & Chariot, A. (2010). BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1. Journal of Biological Chemistry, 285 (33), 25831–25840. doi:10.1074/jbc.M110.112128
Peer Reviewed verified by ORBi

Robert, I., Aussems, M., Keutgens, A., Zhang-Shao, X., Hennuy, B., Viatour, P., Vanstraelen, G., Merville, M.-P., Chapelle, J.-P., de Leval, L., LAMBERT, F., Dejardin, E., Gothot, A., & Chariot, A. (02 April 2009). Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-κB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes. Oncogene, 28 (13), 1626-1638. doi:10.1038/onc.2009.6
Peer Reviewed verified by ORBi

Keutgens, A., Robert, I., Viatour, P., & Chariot, A. (30 October 2006). Deregulated NF-kappa B activity in haematological malignancies. Biochemical Pharmacology, 72 (9), 1069-1080. doi:10.1016/j.bcp.2006.06.011
Peer Reviewed verified by ORBi

Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (January 2005). Phosphorylation of NF-kappa B and I kappa B proteins: implications in cancer and inflammation [letter to the editor]. Trends in Biochemical Sciences, 30 (1), 43-52. doi:10.1016/j.tibs.2004.11.009
Peer Reviewed verified by ORBi

Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (December 2004). Protein phosphorylation as a key mechanism for the regulation of BCL-3 activity. Cell Cycle, 3 (12), 1498-1501. doi:10.4161/cc.3.12.1328
Peer Reviewed verified by ORBi

Viatour, P., Dejardin, E., Warnier, M., Lair, F., Claudio, E., Bureau, F., Marine, J. C., Merville, M.-P., Maurer, U., Green, D., Piette, J., Siebenlist, U., Bours, V., & Chariot, A. (08 October 2004). GSK3-Mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. Molecular Cell, 16 (1), 35-45. doi:10.1016/j.molcel.2004.09.004
Peer Reviewed verified by ORBi

Viatour, P., Legrand-Poels, S., van Lint, C., Warnier, M., Merville, M.-P., Gielen, J.-L., Piette, J., Bours, V., & Chariot, A. (21 November 2003). Cytoplasmic I kappa B alpha increases NF-kappa B-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3. Journal of Biological Chemistry, 278 (47), 46541-46548. doi:10.1074/jbc.M306381200
Peer Reviewed verified by ORBi

Viatour, P., Bentires-Alj, M., Chariot, A., Deregowski, V., de Leval, L., Merville, M.-P., & Bours, V. (July 2003). NF-kappa B2/p100 induces Bcl-2 expression. Leukemia, 17 (7), 1349-1356. doi:10.1038/sj.leu.2402982
Peer Reviewed verified by ORBi

Viatour, P., Legrand-Poels, S., Van Lint, C., Warnier, M., Merville, M.-P., Gielen, J., Piette, J., BOURS, V., & Chariot, A. (2003). Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histones deacetylases (HDAC1 and HDAC3). Journal of Biological Chemistry.
Peer Reviewed verified by ORBi

Bentires-Alj, M., Dejardin, E., Viatour, P., Van Lint, C., Froesch, B., Reed, J. C., Merville, M.-P., & Bours, V. (11 May 2001). Inhibition of the Nf-Kappa B Transcription Factor Increases Bax Expression in Cancer Cell Lines. Oncogene, 20 (22), 2805-13. doi:10.1038/sj.onc.1204343
Peer Reviewed verified by ORBi

Bours, V., Bentires-Alj, M., Hellin, A.-C., Viatour, P., Robe, P., Delhalle, S., Benoit, V., & Merville, M.-P. (15 October 2000). Nuclear Factor-Kappa B, Cancer, and Apoptosis. Biochemical Pharmacology, 60 (8), 1085-9. doi:10.1016/S0006-2952(00)00391-9
Peer Reviewed verified by ORBi

Contact ORBi